Tag: Dr. Prabhu Vinayagam
Facing the Silent Threat: How AMR Imperils Our Future
Antimicrobial resistance poses a silent yet formidable threat to global health, economic stability, and societal well-being, writes Dr Prabhu Vinayagam
BioVoice eMagazine October 2024 | Issue 6 | Volume 5
The Cover Story focuses on the impact of BIOE3 policy. Read Special Interview of Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research. Expert Insights by Dr Prabhu Vinayagam, Medical Advisor, Orchid AMS and Shashank Avadhani, CEO and Co-founder, Alyve Health. Special stories on MPox virus, AMR and AgriTech.
Orchid Pharma makes key appointments for its newly opened AMR division
The company has appointed Dr. Prabhu Vinayagam as Medical Advisor for its newly formed division, Orchid AMS, and hired Amitabh Mazumdar as GM- Sales & Marketing.